Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 100 entries
View as:

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00951600 Org: User:
Start: 09/30/06 End: 12/31/06 Due: 12/31/07

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00778466 Org: User:
Start: 02/28/06 End: 04/30/06 Due: 04/30/07

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00778232 Org: User:
Start: 10/31/02 End: 11/30/02 Due: 11/30/03

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00779376 Org: User:
Start: 02/28/05 End: 04/30/05 Due: 04/30/06

Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00775372 Org: User:
Start: 09/30/05 End: 12/31/05 Due: 12/31/06

A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01499771 Org: User:
Start: 10/31/09 End: 12/31/09 Due: 12/31/10

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01079065 Org: User:
Start: 11/30/07 End: 12/31/07 Due: 12/31/08

A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01222910 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02306889 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00775827 Org: User:
Start: 11/30/02 End: 12/31/02 Due: 12/31/03

A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal

Phase: N/A Priority: Normal
NCT ID: NCT00778349 Org: User:
Start: 04/30/02 End: 07/31/02 Due: 07/31/03

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00778661 Org: User:
Start: 10/31/02 End: 12/31/02 Due: 12/31/03

Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00779051 Org: User:
Start: 08/31/05 End: 10/31/05 Due: 10/31/06

Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00778791 Org: User:
Start: 04/30/04 End: 07/31/04 Due: 07/31/05

Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00775177 Org: User:
Start: 06/30/05 End: 08/31/05 Due: 08/31/06

Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02197442 Org: User:
Start: 01/31/14 End: 03/31/14 Due: 03/31/15

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01523093 Org: User:
Start: 07/31/06 End: 10/31/06 Due: 10/31/07

Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00779350 Org: User:
Start: 08/31/05 End: 10/31/05 Due: 10/31/06

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00776217 Org: User:
Start: 06/30/06 End: 09/30/06 Due: 09/30/07

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01079052 Org: User:
Start: 11/30/07 End: 12/31/07 Due: 12/31/08

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02306902 Org: User:
Start: 10/31/09 End: 04/30/10 Due: 04/30/11

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study

Phase: N/A Priority: Normal
NCT ID: NCT01654705 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00778739 Org: User:
Start: 06/30/05 End: 07/31/05 Due: 07/31/06

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00775255 Org: User:
Start: 09/30/05 End: 12/31/05 Due: 12/31/06

Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00778180 Org: User:
Start: 10/31/05 End: 11/30/05 Due: 11/30/06